Connection
Judith Shlay to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications Judith Shlay has written about Reverse Transcriptase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.553 |
|
|
|
-
Shlay JC, Sharma S, Peng G, Gibert CL, Grunfeld C. Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine. J Acquir Immune Defic Syndr. 2008 May 01; 48(1):53-62.
Score: 0.286
-
Shlay JC, Bartsch G, Peng G, Wang J, Grunfeld C, Gibert CL, Visnegarwala F, Raghavan SS, Xiang Y, Farrough M, Perry HE, Kotler D, El-Sadr WM. Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy. J Acquir Immune Defic Syndr. 2007 Apr 15; 44(5):506-17.
Score: 0.266